Regular, self-reported symptom screening was associated with reduced symptom burden when compared with usual care for pediatric patients with cancer, according to new research led by scientists at the ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TScan Therapeutics (TCRX – Research ...

Perspective Therapeutics, Inc. ( (CATX) ) has released its Q3 earnings. Here is a breakdown of the information Perspective Therapeutics, Inc.

Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...